Navigation Links
Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study

  • Independent Japanese study demonstrates dramatic benefits of adding Diovan to conventional therapy
  • Study halted early due to superior outcomes for Diovan patients
BASEL, Switzerland, April 27, 2007 - New findings from the independent Jikei Heart Study, published today in The Lancet[1], show that adding the blood pressure lowering medication Diovan® to conventional therapy produced a dramatic 39% reduction in cardiovascular events and a 40% reduction in stroke.
The superior benefits reported with Diovan led to an early termination of the study, which involved more than 3,000 Japanese patients.
In addition to its impact on overall cardiovascular events and stroke, Diovan demonstrated relative reductions of 65% in angina pectoris (recurring acute chest pain), 46% in heart failure and 81% in aortic dissection (separation of the wall layers in the body's main artery) compared to other treatment groups1. According to the investigators, these benefits cannot be explained by a difference in blood pressure alone. There were few adverse events (2.5% overall) with no significant difference in tolerability between the groups.
"The results of this trial carry an important clinical message for physicians across the globe who are trying to protect patients from debilitating complications such as stroke," said Gordon McInnes, MD, Professor of Medicine at the Western Infirmary in Glasgow, Scotland. "Jikei Heart tells us that adding Diovan to usual treatment regimens can offer substantial long-term protection."
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
2. Tekturna, First New Type of High Blood Pressure Medicine in a Decade, Provides Additional Blood Pressure Reduction When Used With Diovan
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
5. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
6. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
9. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
10. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
11. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
Post Your Comments:
(Date:9/3/2015)... 03, 2015 Research ... addition of the "Global Craniomaxillofacial (CMF) Devices ... The global craniomaxillofacial devices market to grow ... This report covers the present and future scenario ... To calculate the market size, we use revenues ...
(Date:9/3/2015)... , Sept. 3, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Wells Fargo Healthcare Conference at 8:50 a.m. ET on ... 9-10, 2015 at The Hyatt Regency, Boston ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4q3mv2/investigation ) has announced the ... Market, 2010-2019" report to their offering. ... Sankyo Pharmaceuticals Co., Ltd and was patented in many ... FDA to enter the American market in May. It ... world after it succeeded in the US market. ...
Breaking Medicine Technology:Global Craniomaxillofacial (CMF) Devices Market 2015-2019 - Product Innovation and Cost Reduction a Key Market Trend 2HeartWare Presentation At The 2015 Wells Fargo Healthcare Conference To Be Webcast 2China Olmesartan Investigation Market Report 2010-2019 2
... Inc. (NTI(R)) (Nasdaq: NTII ) today ... has determined that the current clinical,trials of Viprinex(TM) ... unlikely,to show benefit. As a result, the company ... obtain and analyze the data before evaluating the,potential ...
... Disease , , SARASOTA, ... that its researchers have uncovered a new link between ... target for developing novel therapeutics for intervention in this ... Bakshi, Ph.D., is detailed in the American Chemical ...
Cached Medicine Technology:Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3
(Date:9/3/2015)... ... September 03, 2015 , ... Today, Splashtop announced ... customers, as part of the LANDESK One Partner program. Splashtop remote ... best mobile user experience in remote access and control:, , ...
(Date:9/3/2015)... St. Louis, MO (PRWEB) , ... September 03, 2015 , ... ... NBC Nightly News*, covering the allegations made by IVC filter lawsuits filed ... allege they were harmed when a Bard IVC filter broke or failed, have recently ...
(Date:9/3/2015)... ... September 03, 2015 , ... For the ... its Annual Inc. 5000 list of fastest-growing private companies in America. President ... of the nation's companies have demonstrated such remarkably consistent high growth, particularly in ...
(Date:9/3/2015)... ... 03, 2015 , ... Dr. Robert Winchell has been appointed director of the ... at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 27. He will serve on the faculty ... care for the critically injured and the development, design and operations of trauma systems. ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Act (ACA) triggering cost increases for fully insured employer-sponsored health insurance plans, more ... employers (1,000+ employees), according to data released from the 2014 United Benefit Advisors ...
Breaking Medicine News(10 mins):Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 2Health News:Bard IVC Lawsuit Allegations Reach National Prime Time News 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4
... with a sci-fi battle in a galaxy far, far ... and compact disc players. However, an ultra-fast, ultra-intense laser, ... of a second, otherwise known as one femtosecond, could ... joint implant surgeries. , The femtosecond laser has ...
... Leventhal, Esq.,Founder and President of Leventhal Weight ... first in the nation executive,weight loss coaching ... is featured on,the cover of today,s edition ... article,entitled "Accessible Accountability: Attorney,s Weight Loss Company ...
... to Raise Awareness of Health Crisis Affecting More,Than ... the Rise,Worldwide -, WASHINGTON, March 13 ... advocates, dialysis professionals, care,providers and manufacturers working together ... disease and kidney failure -- today recognized,World Kidney ...
... troubling link between boom towns and high rates of substance ... and too little to do. But a recent study of ... of healthy social connections and a need to keep up ... researchers, working with the Canadian Forest Service to conduct the ...
... Test Results Indicate Need for Statewide Phase-out, Says ... artificial,trans fat promotes heart attacks and early deaths, ... serving foods,containing partially hydrogenated oil -- the only ... as McDonald,s, Legal Sea Foods, and Uno,Chicago Grill ...
... March 13 US Script, Inc. announced,today ... has received the Pharmacy Benefit,Management (PBM) Accreditation ... that establishes quality standards for the,healthcare industry. ... the first-ever national standards and service benchmarks ...
Cached Medicine News:Health News:Ultra-fast, ultra-intense laser has clean-cut advantage 2Health News:Leventhal Weight Loss Incorporated President Featured on Cover of Young Lawyer 2Health News:Kidney Care Partners Encourages Policymakers to Support Increased Kidney Care Education and Disease Prevention Programs 2Health News:Study names 5 factors of social ills in energy, mining and logging communities 2Health News:Bay State Restaurants Still Using Artificial Trans Fat Despite Health Risks 2Health News:Bay State Restaurants Still Using Artificial Trans Fat Despite Health Risks 3Health News:US Script Receives URAC Pharmacy Benefit Management Accreditation 2
... walker contains all the features of our other ... in rehabilitation care at an incredibly low price. ... of motion. Walker can be locked at 90 ... and 45 degrees of dorsi or plantar flexion. ...
... walker features a non-skid rocker outsole with ... design minimizes leg length discrepancy. Three hook ... quick and easy. Steel uprights are widere ... and bulky bandaging. Designed for easy application ...
... low cost walker features a non-skid rocker ... low profile design minimizes leg length discrepancies. ... makes strapping quick and easy. Steel uprights ... swollen ankles and extra bandaging. This extra ...
... walker provides comfortable stability for acute ankle ... leg, stress fractures of the lower leg ... ankle. Extension pads for the liner are ... Tide walker with midcalf uprights, is ideal ...
Medicine Products: